다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of gynecologic oncology : jgo, v.23 no.2, 2012년, pp.91 - 97
Kim, Myung Joo (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.) , Jung, Yong Wook (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.) , Seong, Seok Ju (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.) , Yoon, Bo Sung (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.) , Kim, Mi La (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.) , Joo, Won Deok (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.) , Song, Tae Jong (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.)
AI-Helper
ObjectiveTo assess retrospectively the feasibility of intraoperative intraperitoneal (IP) chemotherapy with cisplatin in epithelial ovarian cancer.MethodsIP chemotherapy during optimal staging surgery was performed in 10 patients who were diagnosed with primary epithelial ovarian cancers between Apr...
1 Gadducci A Carnino F Chiara S Brunetti I Tanganelli L Romanini A Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest Gynecol Oncol 2000 76 157 162 10637064
2 Yen MS Juang CM Lai CR Chao GC Ng HT Yuan CC Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer Int J Gynaecol Obstet 2001 72 55 60 11146078
3 Bijelic L Jonson A Sugarbaker PH Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer Ann Oncol 2007 18 1943 1950 17496308
4 Armstrong DK Bundy B Wenzel L Huang HQ Baergen R Lele S Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 2006 354 34 43 16394300
5 Gonzalez-Moreno S Gonzalez-Bayon LA Ortega-Perez G Hyperthermic intraperitoneal chemotherapy: rationale and technique World J Gastrointest Oncol 2010 2 68 75 21160924
6 Frenel JS Leux C Pouplin L Ferron G Berton-Rigaud D Bourbouloux E Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: a pilot study of 31 patients J Surg Oncol 2011 103 10 16 21031424
7 Yan TD Zappa L Edwards G Alderman R Marquardt CE Sugarbaker PH Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database J Surg Oncol 2007 96 102 112 17221852
8 Markman M Bundy BN Alberts DS Fowler JM Clark-Pearson DL Carson LF Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 2001 19 1001 1007 11181662
9 NCI clinical announcement: intraperitoneal chemotherapy for ovarian cancer [Internet] National Cancer Institute 2006 cited 2012 Mar 1 Bethesda, MD National Cancer Institute Available from: http://ctep.cancer.gov/highlights/docs/clin_annc_010506.pdf
10 Markman M Walker JL Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment J Clin Oncol 2006 24 988 994 16461779
11 Kim SW Kim YT Kim JW New paradigm of intraperitoneal chemotherapy in ovarian carcinoma Korean J Gynecol Oncol 2006 17 1 14
12 Walker JL Armstrong DK Huang HQ Fowler J Webster K Burger RA Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group study Gynecol Oncol 2006 100 27 32 16368440
13 Lim MC Kang S Choi J Song YJ Park S Seo SS Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study Ann Surg Oncol 2009 16 993 1000 19169758
14 Dovern E de Hingh IH Verwaal VJ van Driel WJ Nienhuijs SW Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer: a review of achieved results and complications Eur J Gynaecol Oncol 2010 31 256 261 21077465
15 Chua TC Robertson G Liauw W Farrell R Yan TD Morris DL Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results J Cancer Res Clin Oncol 2009 135 1637 1645 19701772
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.